VWR International Locations Join Avantor Performance Materials Distributor Program - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

VWR International Locations Join Avantor Performance Materials Distributor Program

PTSM: Pharmaceutical Technology Sourcing and Management
Volume 10, Issue 2

Avantor Performance Materials, a manufacturer of performance materials and chemicals, has added several VWR International locations in North America to its Certified Excipient Distributor (CED) program for 2014. VWR is a global solutions provider of laboratory supplies, equipment, and services. The company is a long-time distributor of Avantor products, including J.T. Baker, and Macron Fine Chemicals brand products used in pharmaceutical production, laboratory testing, and electronics manufacturing.

The certified VWR sites are located in the Pacific Northwest, West Coast and Puerto Rico, and in the Atlanta, Boston, Chicago, and Philadelphia metro areas. Launched in 2008, Avantor’s CED program is a partnership between Avantor and select chemical distributors to provide pharmaceutical manufacturing customers with a supply chain that complies with industry best practices.

Source: Avantor Performance Materials


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: PTSM: Pharmaceutical Technology Sourcing and Management,
Click here